201 related articles for article (PubMed ID: 29254935)
21. Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration.
ElShelmani H; Brennan I; Kelly DJ; Keegan D
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830203
[TBL] [Abstract][Full Text] [Related]
22. Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction.
Lee JS; Kim M; Seong MW; Kim HS; Lee YK; Kang HJ
Clin Chem Lab Med; 2020 Mar; 58(4):527-532. PubMed ID: 31874093
[TBL] [Abstract][Full Text] [Related]
23. Droplet digital polymerase chain reaction-based quantification of circulating microRNAs using small RNA concentration normalization.
Das Gupta S; Ndode-Ekane XE; Puhakka N; Pitkänen A
Sci Rep; 2020 Jun; 10(1):9012. PubMed ID: 32488181
[TBL] [Abstract][Full Text] [Related]
24. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
25. Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer.
Canale M; Marisi G; Passardi A; Scarpi E; Ulivi P
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30933052
[TBL] [Abstract][Full Text] [Related]
26. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
27. Analysis of circulating microRNA during early gestation in Japanese black cattle.
Ono K; Okamoto S; Ninomiya C; Toji N; Kanazawa T; Ishiguro-Oonuma T; Takahashi T; Iga K; Kizaki K
Domest Anim Endocrinol; 2022 Apr; 79():106706. PubMed ID: 34973621
[TBL] [Abstract][Full Text] [Related]
28. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.
Azad TD; Chaudhuri AA; Fang P; Qiao Y; Esfahani MS; Chabon JJ; Hamilton EG; Yang YD; Lovejoy A; Newman AM; Kurtz DM; Jin M; Schroers-Martin J; Stehr H; Liu CL; Hui AB; Patel V; Maru D; Lin SH; Alizadeh AA; Diehn M
Gastroenterology; 2020 Feb; 158(3):494-505.e6. PubMed ID: 31711920
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the Distribution Profiles of Circulating MicroRNAs by Asymmetrical Flow Field Flow Fractionation.
Flack K; Jimenez LA; Zhong W
Methods Mol Biol; 2017; 1509():161-168. PubMed ID: 27826926
[TBL] [Abstract][Full Text] [Related]
30. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
[TBL] [Abstract][Full Text] [Related]
31. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.
Bernard V; Kim DU; San Lucas FA; Castillo J; Allenson K; Mulu FC; Stephens BM; Huang J; Semaan A; Guerrero PA; Kamyabi N; Zhao J; Hurd MW; Koay EJ; Taniguchi CM; Herman JM; Javle M; Wolff R; Katz M; Varadhachary G; Maitra A; Alvarez HA
Gastroenterology; 2019 Jan; 156(1):108-118.e4. PubMed ID: 30240661
[TBL] [Abstract][Full Text] [Related]
32. Pre-amplification as a method for improvement of quantitative RT-PCR analysis of circulating miRNAs.
Sekovanić A; Dorotić A; Jurasović J; Pašalić D; Kovačić J; Stasenko S; Mioč T; Piasek M; Orct T
Biochem Med (Zagreb); 2021 Feb; 31(1):010901. PubMed ID: 33380895
[TBL] [Abstract][Full Text] [Related]
33. Using Liquid Biopsy in the Treatment of Patient with OS.
Shulman DS; Crompton BD
Adv Exp Med Biol; 2020; 1257():95-105. PubMed ID: 32483734
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma.
Warton K; Yuwono NL; Cowley MJ; McCabe MJ; So A; Ford CE
Mol Diagn Ther; 2017 Oct; 21(5):563-570. PubMed ID: 28631163
[TBL] [Abstract][Full Text] [Related]
35. Overcoming Heparin-Associated RT-qPCR Inhibition and Normalization Issues for microRNA Quantification in Patients with Acute Myocardial Infarction.
Coelho-Lima J; Mohammed A; Cormack S; Jones S; Das R; Egred M; Panahi P; Ali S; Spyridopoulos I
Thromb Haemost; 2018 Jul; 118(7):1257-1269. PubMed ID: 29890520
[TBL] [Abstract][Full Text] [Related]
36. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
[TBL] [Abstract][Full Text] [Related]
37. Droplet Digital PCR for Absolute Quantification of Extracellular MicroRNAs in Plasma and Serum: Quantification of the Cancer Biomarker hsa-miR-141.
Giraldez MD; Chevillet JR; Tewari M
Methods Mol Biol; 2018; 1768():459-474. PubMed ID: 29717459
[TBL] [Abstract][Full Text] [Related]
38. Quantification of Circulating MicroRNAs by Droplet Digital PCR.
Ferracin M; Negrini M
Methods Mol Biol; 2018; 1768():445-457. PubMed ID: 29717458
[TBL] [Abstract][Full Text] [Related]
39. Circulating plasma microRNA signature for the diagnosis of cervical cancer.
Ma G; Song G; Zou X; Shan X; Liu Q; Xia T; Zhou X; Zhu W
Cancer Biomark; 2019; 26(4):491-500. PubMed ID: 31658043
[TBL] [Abstract][Full Text] [Related]
40. Normalization matters: tracking the best strategy for sperm miRNA quantification.
Corral-Vazquez C; Blanco J; Salas-Huetos A; Vidal F; Anton E
Mol Hum Reprod; 2017 Jan; 23(1):45-53. PubMed ID: 27932553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
